Výsledky vyhledávání - Agda Karina Eterovic

Upřesnit hledání
  1. 1
    Bias from removing read duplication in ultra-deep sequencing experiments

    Bias from removing read duplication in ultra-deep sequencing experiments Autor Wanding Zhou, Tenghui Chen, Hao Zhao, Agda Karina Eterovic, Funda Meric‐Bernstam, Gordon B. Mills, Ken Chen

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    The neutrophil-to-lymphocyte ratio: a narrative review

    The neutrophil-to-lymphocyte ratio: a narrative review Autor Sara Socorro Faria, Paulo César Fernandes, Marcelo José Barbosa Silva, Vladmir Cláudio Cordeiro de Lima, Wagner Fontes, Ruffo Freitas‐Júnior, Agda Karina Eterovic, Patrice Forget

    Vydáno 2016
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma

    Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma Autor Jad Chahoud, Frederico O. Gleber‐Netto, Barrett Z. McCormick, Priya Rao, Xin Lü, Ming Guo, Maggaret B. Morgan, Randy Chu, Magaly Martínez‐Ferrer, Agda Karina Eterovic, Curtis R. Pickering, Curtis A. Pettaway

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Molecular characterization of gallbladder cancer using somatic mutation profiling

    Molecular characterization of gallbladder cancer using somatic mutation profiling Autor Milind Javle, Asif Rashid, Chaitanya Churi, Siddhartha Kar, Mingxin Zuo, Agda Karina Eterovic, Graciela M. Nogueras‐González, Filip Janků, Rachna T. Shroff, Thomas A. Aloia, J.N. Vauthey, Steven A. Curley, Gordon B. Mills, Iván Roa

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors

    Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors Autor B. Hassan, Argun Akçakanat, Takafumi Sangai, Kurt W. Evans, Farrell Adkins, Agda Karina Eterovic, Hao Zhao, Ken Chen, Huiqin Chen, Kim‐Anh Do, Shelly M. Xie, Ashley M. Holder, Aung Naing, Gordon B. Mills, Funda Meric‐Bernstam

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors

    A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors Autor Kurt W. Evans, Erkan Yuca, Argun Akçakanat, Stephen Scott, Natalia Paez Arango, Xiaofeng Zheng, Ken Chen, Coya Tapia, Emily Tarco, Agda Karina Eterovic, Dalliah M. Black, Jennifer K. Litton, Timothy A. Yap, Debu Tripathy, Gordon B. Mills, Funda Meric‐Bernstam

    Vydáno 2017
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations

    Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations Autor Michael T. Tetzlaff, Jonathan L. Curry, Jing Ning, Oded Sagiv, Thomas L. Kandl, Bo Peng, Diana Bell, Mark J. Routbort, Courtney W. Hudgens, Doina Ivan, Tae-Boom Kim, Ken Chen, Agda Karina Eterovic, Kenna Shaw, Víctor G. Prieto, Anna Yemelyanova, Bita Esmaeli

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    The degree of intratumor mutational heterogeneity varies by primary tumor sub-site

    The degree of intratumor mutational heterogeneity varies by primary tumor sub-site Autor Levi Ledgerwood, Dhruv Kumar, Agda Karina Eterovic, Jo Wick, Ken Chen, Hao Zhao, Loubna Tazi, Pradip Manna, Spencer Kerley, Radhika Joshi, Lin Wang, Simion I. Chiosea, James D. Garnett, Terance T. Tsue, Jeremy Chien, Gordon B. Mills, Jennifer R. Grandis, Sufi M. Thomas

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer

    Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer Autor Funda Meric‐Bernstam, Xiaofeng Zheng, Maryam Shariati, Senthil Damodaran, Chetna Wathoo, Lauren Brusco, Mehmet Demirhan, Coya Tapia, Agda Karina Eterovic, Reva Basho, Naoto T. Ueno, Filip Janků, Ayşegül A. Şahin, Jordi Rodón, Russell Broaddus, Tae-Beom Kim, John Mendelsohn, Kenna Shaw, Debu Tripathy, Gordon B. Mills, Ken Chen

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma

    Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma Autor Meredith McKean, Junna Oba, Junsheng Ma, Katherine G. Roth, Wei‐Lien Wang, Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Lauren E. Haydu, Alan Siroy, Phuong Vo, David S. Hong, Agda Karina Eterovic, Keyur P. Patel, Roland L. Bassett, Elizabeth A. Grimm, Alexander J. Lazar, Scott E. Woodman

    Vydáno 2018
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  11. 11
    A Decision Support Framework for Genomically Informed Investigational Cancer Therapy

    A Decision Support Framework for Genomically Informed Investigational Cancer Therapy Autor Funda Meric‐Bernstam, Amber M. Johnson, Vijaykumar Holla, Ann M. Bailey, Lauren Brusco, Ken Chen, Mark J. Routbort, Keyur P. Patel, Jia Zeng, Scott Kopetz, Michael A. Davies, Sarina A. Piha‐Paul, David S. Hong, Agda Karina Eterovic, Apostolia M. Tsimberidou, Russell Broaddus, Elmer V. Bernstam, Kenna Shaw, John Mendelsohn, Gordon B. Mills

    Vydáno 2015
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancers

    Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancers Autor Chaoyang Sun, Yong Fang, Jun‐Jie Yin, Jian Chen, Zhenlin Ju, Dong Zhang, Xiaohua Chen, Christopher P. Vellano, Kang Jin Jeong, Patrick Kwok‐Shing Ng, Agda Karina Eterovic, Neil E. Bhola, Yiling Lu, Shannon N. Westin, Jennifer R. Grandis, Shiaw‐Yih Lin, Kenneth L. Scott, Guang Peng, Joan S. Brugge, Gordon B. Mills

    Vydáno 2017
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol

    Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol Autor Funda Meric‐Bernstam, Lauren Brusco, Molly S. Daniels, Chetna Wathoo, Ann M. Bailey, Louise C. Strong, Kenna Shaw, Karen H. Lu, Yuan Qi, Hao Zhao, Humberto Lara-Guerra, Jennifer K. Litton, Banu K. Arun, Agda Karina Eterovic, Ugur Aytac, Mark J. Routbort, Vivek Subbiah, Filip Janků, Michael A. Davies, Scott Kopetz, John Mendelsohn, Gordon B. Mills, Ken Chen

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes

    Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes Autor Priscilla F. McAuliffe, Kurt W. Evans, Argun Akçakanat, Ken Chen, Xiaofeng Zheng, Hao Zhao, Agda Karina Eterovic, Takafumi Sangai, Ashley M. Holder, Chandeshwar Sharma, Huiqin Chen, Kim‐Anh Do, Emily Tarco, Mihai Gagea, Katherine A. Naff, Ayşegül A. Şahin, Asha S. Multani, Dalliah M. Black, Elizabeth A. Mittendorf, Isabelle Bedrosian, Gordon B. Mills, Ana M. González-Angulo, Funda Meric‐Bernstam

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Clinical Actionability Enhanced through Deep Targeted Sequencing of Solid Tumors

    Clinical Actionability Enhanced through Deep Targeted Sequencing of Solid Tumors Autor Ken Chen, Funda Meric‐Bernstam, Hao Zhao, Qingxiu Zhang, Nader Ezzeddine, Lin-Ya Tang, Yuan Qi, Yong Mao, Tenghui Chen, Zechen Chong, Wanding Zhou, Xiaofeng Zheng, Amber M. Johnson, Kenneth Aldape, Mark J. Routbort, Rajyalakshmi Luthra, Scott Kopetz, Michael A. Davies, John de Groot, Stacy Moulder, Vinod Ravi, Carol Farhangfar, Kenna M. Shaw, John Mendelsohn, Gordon B. Mills, Agda Karina Eterovic

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer

    Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer Autor Chuncheng Hao, Li Wang, Shaohua Peng, Mengru Cao, Hongyu Li, Jing Hu, Xiao Huang, Wei Liu, Hui Zhang, Shuhong Wu, Apar Pataer, John V. Heymach, Agda Karina Eterovic, Qingxiu Zhang, Kenna Shaw, Ken Chen, P. Andrew Futreal, Michael Wang, Wayne L. Hofstetter, Reza J. Mehran, David C. Rice, Jack A. Roth, Boris Sepesi, Stephen G. Swisher, Ara A. Vaporciyan, Garrett L. Walsh, Faye M. Johnson, Bingliang Fang

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

    Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays Autor Jun Li, Wei Zhao, Rehan Akbani, Wenbin Liu, Zhenlin Ju, Shiyun Ling, Christopher P. Vellano, Paul Roebuck, Qinghua Yu, Agda Karina Eterovic, Lauren A. Byers, Michael A. Davies, Wanleng Deng, Y.N. Vashisht Gopal, Guo Chen, Erika M. von Euw, Dennis J. Slamon, Dylan Conklin, John V. Heymach, Adi F. Gazdar, John D. Minna, Jeffrey N. Myers, Yiling Lu, Gordon B. Mills, Han Liang

    Vydáno 2017
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis

    Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis Autor Einav Shoshan, Aaron K. Mobley, Russell R. Braeuer, Takafumi Kamiya, Huang Li, Mayra E. Vasquez, Ahmad Salameh, Ho Jeong Lee, Sun Jin Kim, Cristina Ivan, Guermarie Velázquez-Torres, Ka Ming Nip, Kelsey Zhu, Denise Brooks, Steven J.M. Jones, İnanç Birol, M. Mosqueda, Yu-Ye Wen, Agda Karina Eterovic, Anil K. Sood, Patrick Hwu, Hui Shen, A. Gordon Robertson, George A. Călin, Gal Markel, Isaiah J. Fidler, Menashe Bar‐Eli

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

    Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation Autor Yan Xing, Nancy U. Lin, Matthew Maurer, Huiqin Chen, Armeen Mahvash, Ayşegül A. Şahin, Argun Akçakanat, Yisheng Li, Vandana G. Abramson, Jennifer K. Litton, Mariana Chávez‐MacGregor, Vicente Valero, Sarina A. Piha‐Paul, David S. Hong, Kim‐Anh Do, Emily Tarco, Dianna Riall, Agda Karina Eterovic, Gerburg M. Wulf, Lewis C. Cantley, Gordon B. Mills, L. Austin Doyle, Eric P. Winer, Gabriel N. Hortobágyi, Ana M. González-Angulo, Funda Meric‐Bernstam

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set

    Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set Autor Jason Roszik, Lauren E. Haydu, Kenneth R. Hess, Junna Oba, Aron Y. Joon, Alan Siroy, Tatiana V. Karpinets, Francesco C. Stingo, Veera Baladandayuthapani, Michael T. Tetzlaff, Jennifer A. Wargo, Ken Chen, Marie-Andrée Forget, Cara Haymaker, Jie Qing Chen, Funda Meric‐Bernstam, Agda Karina Eterovic, Kenna Shaw, Gordon B. Mills, Jeffrey E. Gershenwald, Laszlo Radvanyi, Patrick Hwu, P. Andrew Futreal, Don L. Gibbons, Alexander J. Lazar, Chantale Bernatchez, Michael A. Davies, Scott E. Woodman

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: